ASD Prevalence Study across Europe: Strategy Design based on two different methodologies


Background and objectives / introduction Over the past 30 years the number of reported cases of ASD has increased. Consequently, ASD organizations are requesting more services and pressuring governments to respond. The few... [ view full abstract ]

Ethics and permissions statement and / or disclosure of potential conflict of interest (if relevant)

Authors have not conflicts of interest and prevalence study is being submitted to the ethics committees of each country [ view full abstract ]


  1. PATRICIA GARCÍA-PRIMO (Spanish Foundation for International Cooperation, Health and Social Policy (FCSAI))
  2. Astrid Vicente (Instituto Nacional de Saúde Doutor Ricardo Jorge)
  3. Bernadette Rogé (University Toulouse 2 Jean Jaurès UT2J)
  4. Catherine Arnaud (University Toulouse 3 Paul Sabatier)
  5. Diana Schendel (University of Aarhus)
  6. Evald Saemundsen (State Diagnostic and Counselling Centre)
  7. Filippo Muratori (IRCCS Stella Maris Foundation, Pisa (Calambrone), Italy)
  8. Joaquín Fuentes (Fundación Policlínica Gipuzkoa)
  9. Luise Poustka (Medical University of Vienna)
  10. Maria Luisa Scatonni (Istituto Superiore di Sanità)
  11. Mika Gissler (University and University Hospital of Oulu)
  12. Mary Rose Sweeny (Dublin City University, School of Nursing and Human Sciences)
  13. Magdalena Efrim (Victor Babes” National Institute of Pathology)
  14. Rafal Kawa (University of Warsaw)
  15. Ricardo Canal-Bedia (University of Salamanca)
  16. Rumen Stefanov (Bulgarian Association for Promotion of Education and Science)
  17. Manuel Posada (Institute of Rare Diseases Research, ISCIII)

Topic Area

Topics: Research


V10 » Oral Posters: Screening, diagnosis and assessment III (16:20 - Saturday, 17th September, Moorfoot Room)